2021 Form 10-K Financial Statement
#000121390022017017 Filed on April 01, 2022
Income Statement
| Concept | 2021 | 2020 |
|---|---|---|
| Revenue | $37.35M | $37.91M |
| YoY Change | -1.49% | 9.41% |
| Cost Of Revenue | $26.29M | $31.55M |
| YoY Change | -16.66% | 11.03% |
| Gross Profit | $11.06M | $6.363M |
| YoY Change | 73.75% | 2.03% |
| Gross Profit Margin | 29.61% | 16.79% |
| Selling, General & Admin | $20.46M | $12.42M |
| YoY Change | 64.78% | 96.86% |
| % of Gross Profit | 185.08% | 195.16% |
| Research & Development | $7.401M | $6.245M |
| YoY Change | 18.51% | -2.62% |
| % of Gross Profit | 66.93% | 98.13% |
| Depreciation & Amortization | $3.782M | $1.966M |
| YoY Change | 92.37% | 1828.82% |
| % of Gross Profit | 34.21% | 30.9% |
| Operating Expenses | $31.65M | $20.63M |
| YoY Change | 53.4% | 60.88% |
| Operating Profit | -$20.59M | -$14.27M |
| YoY Change | 44.32% | 116.6% |
| Interest Expense | $49.13K | |
| YoY Change | -32.1% | |
| % of Operating Profit | ||
| Other Income/Expense, Net | $474.5K | -$292.8K |
| YoY Change | -262.08% | |
| Pretax Income | -$20.11M | -$14.51M |
| YoY Change | 38.63% | 122.74% |
| Income Tax | $11.88K | $0.00 |
| % Of Pretax Income | ||
| Net Earnings | -$20.13M | -$14.51M |
| YoY Change | 38.71% | 121.8% |
| Net Earnings / Revenue | -53.89% | -38.27% |
| Basic Earnings Per Share | -$0.95 | |
| Diluted Earnings Per Share | -$949.9K | -$1.144M |
| COMMON SHARES | ||
| Basic Shares Outstanding | 21.19M shares | 12.68M shares |
| Diluted Shares Outstanding | 21.19M |
Balance Sheet
| Concept | 2021 | 2020 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $1.564M | $3.479M |
| YoY Change | -55.05% | 17.03% |
| Cash & Equivalents | $1.564M | $3.479M |
| Short-Term Investments | ||
| Other Short-Term Assets | $918.8K | $1.176M |
| YoY Change | -21.86% | -57.25% |
| Inventory | ||
| Prepaid Expenses | ||
| Receivables | $11.17M | $8.292M |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $13.66M | $12.95M |
| YoY Change | 5.49% | 20.77% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $154.0K | $178.6K |
| YoY Change | -13.77% | |
| Goodwill | ||
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | ||
| YoY Change | ||
| Total Long-Term Assets | $20.53M | $16.99M |
| YoY Change | 20.81% | 2678.53% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $13.66M | $12.95M |
| Total Long-Term Assets | $20.53M | $16.99M |
| Total Assets | $34.19M | $29.94M |
| YoY Change | 14.18% | 164.22% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $2.294M | $1.087M |
| YoY Change | 111.08% | 1302.19% |
| Accrued Expenses | $1.896M | $1.275M |
| YoY Change | 48.73% | 327.06% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $2.911M |
| YoY Change | -100.0% | |
| Long-Term Debt Due | ||
| YoY Change | ||
| Total Short-Term Liabilities | $4.601M | $5.520M |
| YoY Change | -16.64% | 1368.16% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $10.00K | $517.1K |
| YoY Change | -98.07% | 3.41% |
| Other Long-Term Liabilities | ||
| YoY Change | ||
| Total Long-Term Liabilities | $10.00K | $517.1K |
| YoY Change | -98.07% | 3.41% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $4.601M | $5.520M |
| Total Long-Term Liabilities | $10.00K | $517.1K |
| Total Liabilities | $4.611M | $6.037M |
| YoY Change | -23.61% | 589.15% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | ||
| YoY Change | ||
| Common Stock | ||
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $29.58M | $23.90M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $34.19M | $29.94M |
| YoY Change | 14.18% | 164.22% |
Cashflow Statement
| Concept | 2021 | 2020 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$20.13M | -$14.51M |
| YoY Change | 38.71% | 121.8% |
| Depreciation, Depletion And Amortization | $3.782M | $1.966M |
| YoY Change | 92.37% | 1828.82% |
| Cash From Operating Activities | -$16.86M | -$11.97M |
| YoY Change | 40.76% | 73.13% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | ||
| YoY Change | ||
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | -$933.7K | $3.804M |
| YoY Change | -124.54% | -239.32% |
| Cash From Investing Activities | -$933.7K | $3.804M |
| YoY Change | -124.54% | -239.32% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | 15.89M | 8.688M |
| YoY Change | 82.85% | -26.92% |
| NET CHANGE | ||
| Cash From Operating Activities | -16.86M | -11.97M |
| Cash From Investing Activities | -933.7K | 3.804M |
| Cash From Financing Activities | 15.89M | 8.688M |
| Net Change In Cash | -1.904M | 517.1K |
| YoY Change | -468.09% | -76.93% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$16.86M | -$11.97M |
| Capital Expenditures | ||
| Free Cash Flow | ||
| YoY Change |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
USD | |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
shares | |
| CY2021 | dei |
Trading Symbol
TradingSymbol
|
LGIQ | |
| CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
21187556 | shares |
| CY2020 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
12678904 | shares |
| CY2021 | dei |
Auditor Firm
AuditorFirmId
|
2769 | |
| CY2021Q4 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
USD | |
| CY2021Q4 | us-gaap |
Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
|
USD | |
| CY2020Q4 | us-gaap |
Deposit Liability Current
DepositLiabilityCurrent
|
USD | |
| CY2021Q4 | us-gaap |
Other Long Term Notes Payable
OtherLongTermNotesPayable
|
USD | |
| CY2021 | lgiq |
Advances To Associate
AdvancesToAssociate
|
USD | |
| CY2021 | us-gaap |
Repayments Of Bank Debt
RepaymentsOfBankDebt
|
USD | |
| CY2021 | us-gaap |
Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
|
USD | |
| CY2021 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
USD | |
| CY2021 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
USD | |
| CY2020 | lgiq |
Proceeds From Shares To Be Issueds
ProceedsFromSharesToBeIssueds
|
USD | |
| CY2020 | lgiq |
Proceeds From Stock Issuance From Ipo Net Of Expenses
ProceedsFromStockIssuanceFromIPONetOfExpenses
|
USD | |
| CY2019 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
USD | |
| CY2020 | lgiq |
Stock Issued During Period Effect Of Reverse Split Share
StockIssuedDuringPeriodEffectOfReverseSplitShare
|
USD | |
| CY2021Q4 | us-gaap |
Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
|
USD | |
| CY2020Q4 | us-gaap |
Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
|
USD | |
| CY2021 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
USD | |
| CY2021Q4 | us-gaap |
Fair Value Hedge Liabilities At Fair Value
FairValueHedgeLiabilitiesAtFairValue
|
USD | |
| CY2020Q4 | us-gaap |
Fair Value Hedge Liabilities At Fair Value
FairValueHedgeLiabilitiesAtFairValue
|
USD | |
| CY2021Q4 | us-gaap |
Customer Advances Or Deposits Noncurrent
CustomerAdvancesOrDepositsNoncurrent
|
USD | |
| CY2021Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
USD | |
| CY2014Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
USD | |
| CY2015 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
||
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
||
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
||
| CY2015 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
||
| CY2015Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
USD | |
| CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
shares | |
| CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
||
| CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
||
| CY2016 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
||
| CY2016Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
USD | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
shares | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
||
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
||
| CY2018Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
shares | |
| CY2018Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
||
| CY2018Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
||
| CY2018 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
||
| CY2018Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
USD | |
| CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
shares | |
| CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
||
| CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
||
| CY2019 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
||
| CY2019Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
USD | |
| CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
shares | |
| CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
||
| CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
||
| CY2020Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
||
| CY2020Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
USD | |
| CY2017Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
USD | |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
shares | |
| CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
||
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
||
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
||
| CY2021Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
||
| CY2021Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
USD | |
| CY2021 | lgiq |
Vesting Period On Monthly Basis
VestingPeriodOnMonthlyBasis
|
P5Y | |
| CY2021 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
USD |
